• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Capturing chemotherapy drugs before they can cause side effects

Bioengineer by Bioengineer
January 9, 2019
in Biology
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Hee Jeung Oh


Although chemotherapy can kill cancer cells very effectively, healthy cells also suffer. If doctors could remove excess chemotherapy drugs from a patient’s bloodstream after the medicines have done their job, they might reduce side effects such as hair loss and nausea. Now, researchers have developed a 3D-printed device that absorbs excess chemo drugs before they spread throughout the body. They report their results in ACS Central Science.

Doxorubicin, like many chemotherapy drugs, kills more tumor cells when given at higher doses. However, most patients cannot tolerate large amounts of the drug because it can cause heart failure, among other side effects. Nitash Balsara, Steven Hetts, Joseph DeSimone, Hee Jeung Oh and colleagues wondered if they could make a device that would filter out doxorubicin from blood at locations outside of the tumor to reduce the likelihood that the drug would harm healthy cells.

The researchers used a 3D printer to fabricate tiny cylinders made of poly(ethylene glycol) diacrylate. Inside the cylinders was a square lattice structure that would allow blood cells to pass through it, with a copolymer coating that binds to doxorubicin. The researchers tested these absorbers in pigs, inserting them into a vein. When they injected doxorubicin into the same vein, the drug flowed in the bloodstream to the device. By measuring the doxorubicin concentration in the vein at a location after the absorber, the researchers determined that it captured about 64 percent of the drug from the bloodstream. The device could open a new route to help patients fight cancer, enabling reduced side effects or an increased chemotherapy dose, the researchers say.

###

The authors acknowledge funding from the National Institutes of Health, the National Cancer Institute and the U.S. Department of Energy.

The paper’s abstract will be available on January 9 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acscentsci.8b00700

The American Chemical Society, the world’s largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected].

Follow us: Twitter | Facebook

Media Contact
Katie Cottingham
[email protected]
301-775-8455

Tags: cancerCell BiologyChemistry/Physics/Materials SciencesPharmaceutical ChemistryPharmaceutical SciencePharmaceutical SciencesPharmaceutical/Combinatorial Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

Ingestible Capsules Enable Microbe-Based Therapeutic Control

Ingestible Capsules Enable Microbe-Based Therapeutic Control

July 28, 2025
Engineering Receptors to Enhance Flagellin Detection

Engineering Receptors to Enhance Flagellin Detection

July 28, 2025

Decoding FLS2 Unveils Broad Pathogen Detection Principles

July 28, 2025

Archaeal Ribosome Shows Unique Active Site, Hibernation Factor

July 26, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    54 shares
    Share 22 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Advancing Microbial Risk Assessment Through Detection Technology Evolution

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

Virion Movement in Sialoglycan-Cleaving Respiratory Viruses

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.